Harry-Kari
Vital 1st Team Regular
More analysis of the Oxford trial results....
https://www.nytimes.com/2020/11/25/business/coronavirus-vaccine-astrazeneca-oxford.html
When their published results say the double dose regimen average from two different trials in the UK and Brazil produce an efficacy of 62% why would a professor from Edinburgh University I think say that the initial dose provides “up to 80% protection”....unless that is 80% of the 62% efficacy.
There is lots of chatter about not being able to compare the results to those of Pfizer and Moderna vaccines without giving any details as to why with Sara Jarvis the media’s favourite doctor saying it’s like comparing Apples and Oranges but no details as to why.
I’m not a fan of the NY Times but this article does at least explain why people, especially the US medical community are uncertain about the claims for the Oxford vaccine given the way the results seem to be being manipulated as each flaw in the process is highlighted.
https://www.nytimes.com/2020/11/25/business/coronavirus-vaccine-astrazeneca-oxford.html
When their published results say the double dose regimen average from two different trials in the UK and Brazil produce an efficacy of 62% why would a professor from Edinburgh University I think say that the initial dose provides “up to 80% protection”....unless that is 80% of the 62% efficacy.
There is lots of chatter about not being able to compare the results to those of Pfizer and Moderna vaccines without giving any details as to why with Sara Jarvis the media’s favourite doctor saying it’s like comparing Apples and Oranges but no details as to why.
I’m not a fan of the NY Times but this article does at least explain why people, especially the US medical community are uncertain about the claims for the Oxford vaccine given the way the results seem to be being manipulated as each flaw in the process is highlighted.